0

531398

SOURCENTRL

img img img img
No Data Available

SOURCE NATURAL FOODS & HERBAL Share Price Update

As of the latest trading session, SOURCE NATURAL FOODS & HERBAL is trading at ₹129.95, up by ₹2.64 or 2.07% from its previous close. The stock has moved between ₹128.00 and ₹145.00 today. Over the past year, the stock has delivered a return of -22.84%. In the last month, it has returned 17.32%.

Investment Returns

Over 1 Month 17.32% Over 3 Months -7.92% Over 6 Months -17.71% Over 1 Year -22.84%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

SOURCE NATURAL FOODS & HERBAL fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 84.20
  • P/E Ratio (TTM) 29.47
  • Beta 0.63
  • Book Value / share 36.80
  • Return on equity 13.87%
  • EPS (TTM) 4.32
  • Dividend yield [-]%
  • Net profit/quarter (Cr) 0.82
info icon alternate text

SOURCE NATURAL FOODS & HERBAL Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars DEC 2025 (Values in Cr)
Revenue 20.30
Operating Expense 19.18
Net Profit 0.82
Net Profit Margin (%) 4.03
Earnings Per Share (EPS) 1.28
EBITDA 1.52
Effective Tax Rate (%) 26.12
Particulars SEP 2025 (Values in Cr)
Revenue 16.95
Operating Expense 16.00
Net Profit 0.70
Net Profit Margin (%) 4.12
Earnings Per Share (EPS) 1.09
EBITDA 1.36
Effective Tax Rate (%) 26.31
Particulars JUN 2025 (Values in Cr)
Revenue 12.10
Operating Expense 11.26
Net Profit 0.63
Net Profit Margin (%) 5.20
Earnings Per Share (EPS) 0.98
EBITDA 1.26
Effective Tax Rate (%) 25.88
Particulars MAR 2025 (Values in Cr)
Revenue 16.07
Operating Expense 15.26
Net Profit 0.63
Net Profit Margin (%) 3.92
Earnings Per Share (EPS) 0.97
EBITDA 1.28
Effective Tax Rate (%) 27.90
Particulars DEC 2024 (Values in Cr)
Revenue 10.45
Operating Expense 9.23
Net Profit 1.02
Net Profit Margin (%) 9.76
Earnings Per Share (EPS) 1.58
EBITDA 1.67
Effective Tax Rate (%) 16.39
Particulars MAR 2025 (Values in Cr)
Revenue 44.92
Operating Expense 41.41
Net Profit 2.90
Net Profit Margin (%) 6.45
Earnings Per Share (EPS) 4.51
EBITDA 5.22
Effective Tax Rate (%) 18.99
Particulars MAR 2024 (Values in Cr)
Revenue 27.30
Operating Expense 24.08
Net Profit 1.74
Net Profit Margin (%) 6.37
Earnings Per Share (EPS) 2.70
EBITDA 4.43
Effective Tax Rate (%) 45.28
Particulars MAR 2023 (Values in Cr)
Revenue 19.77
Operating Expense 17.06
Net Profit 2.12
Net Profit Margin (%) 10.72
Earnings Per Share (EPS) 3.30
EBITDA 3.60
Effective Tax Rate (%) 22.26
Particulars MAR 2022 (Values in Cr)
Revenue 21.52
Operating Expense 18.33
Net Profit 2.43
Net Profit Margin (%) 11.29
Earnings Per Share (EPS) 3.78
EBITDA 4.25
Effective Tax Rate (%) 33.96
Particulars MAR 2021 (Values in Cr)
Revenue 24.87
Operating Expense 21.17
Net Profit 3.37
Net Profit Margin (%) 13.55
Earnings Per Share (EPS) 5.24
EBITDA 4.50
Effective Tax Rate (%) 16.37
Particulars MAR 2025 (Values in Cr)
Book Value / Share 34.73
ROE % 13.87
ROCE % 16.33
Total Debt to Total Equity 0.21
EBITDA Margin 11.62
Particulars MAR 2024 (Values in Cr)
Book Value / Share 30.22
ROE % 9.36
ROCE % 17.18
Total Debt to Total Equity 0.03
EBITDA Margin 16.23
Particulars MAR 2023 (Values in Cr)
Book Value / Share 27.52
ROE % 12.73
ROCE % 17.43
Total Debt to Total Equity 0.00
EBITDA Margin 18.29
Particulars MAR 2022 (Values in Cr)
Book Value / Share 24.23
ROE % 16.89
ROCE % 25.64
Total Debt to Total Equity 0.03
EBITDA Margin 20.16
Particulars MAR 2021 (Values in Cr)
Book Value / Share 20.45
ROE % 29.36
ROCE % 32.14
Total Debt to Total Equity 0.09
EBITDA Margin 18.09
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 7.22
Total Assets 35.83
Total Liabilities 35.83
Total Equity 22.35
Share Outstanding 0
Price to Book Ratio 5.99
Return on Assets (%) 8.10
Return on Capital (%) 9.76
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 7.09
Total Assets 24.88
Total Liabilities 24.88
Total Equity 19.45
Share Outstanding 0
Price to Book Ratio 2.92
Return on Assets (%) 6.97
Return on Capital (%) 8.39
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 2.91
Total Assets 21.45
Total Liabilities 21.45
Total Equity 17.71
Share Outstanding 0
Price to Book Ratio 3.23
Return on Assets (%) 9.88
Return on Capital (%) 11.96
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.87
Total Assets 19.32
Total Liabilities 19.32
Total Equity 15.59
Share Outstanding 0
Price to Book Ratio 3.92
Return on Assets (%) 12.58
Return on Capital (%) 15.56
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.70
Total Assets 17.22
Total Liabilities 17.22
Total Equity 13.16
Share Outstanding 0
Price to Book Ratio 7.24
Return on Assets (%) 19.58
Return on Capital (%) 23.93
Particulars MAR 2025 (Values in Cr)
Net Income 3.58
Cash from Operations 0.06
Cash from Investing -5.33
Cash from Financing 5.39
Net change in Cash 0.13
Free Cash Flow 0.15
Particulars MAR 2024 (Values in Cr)
Net Income 3.17
Cash from Operations 2.69
Cash from Investing 0.29
Cash from Financing 1.19
Net change in Cash 4.18
Free Cash Flow 2.69
Particulars MAR 2023 (Values in Cr)
Net Income 2.73
Cash from Operations 2.51
Cash from Investing 0.05
Cash from Financing -0.52
Net change in Cash 2.04
Free Cash Flow 2.51
Particulars MAR 2022 (Values in Cr)
Net Income 3.68
Cash from Operations 0.93
Cash from Investing 0.06
Cash from Financing -1.19
Net change in Cash -1.83
Free Cash Flow 2.47
Particulars MAR 2021 (Values in Cr)
Net Income 4.04
Cash from Operations 4.46
Cash from Investing -2.04
Cash from Financing 0.31
Net change in Cash 2.73
Free Cash Flow 5.38
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.80 13.77 1.65 243.69 23.12 40.44
BLISS GVS PHARMA LTD 276.25 26.41 2.58 2922.42 105.05 280.20
CIPLA LTD 1309.90 22.25 3.21 105811.45 1165.55 1672.20
FERMENTA BIOTECH LIMITED 311.40 10.36 2.34 916.48 252.15 399.00
GLAXOSMITHKLINE PHARMA LT 2335.60 39.34 23.16 39566.47 2218.00 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.80 30.58 4.43 243.69 23.12 40.44
AMRUTANJAN HEALTH CARE LTD. 570.45 28.52 4.82 1649.21 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8217.20 98.75 25.71 20543.00 7630.00 10653.05
BLISS GVS PHARMA LTD 276.25 37.64 2.64 2922.42 105.05 280.20

SOURCE NATURAL FOODS & HERBAL shareholding pattern

Holding
25.63%
74.36%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

SOURCE NATURAL FOODS & HERBAL Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
130.80 2.74 redarrow
red-green-graph indicator
3 Bearish
13 Bullish
  • 5 Days 128.30
  • 26 Days 126.30
  • 10 Days 128.00
  • 50 Days 126.90
  • 12 Days 127.70
  • 100 Days 130.40
  • 20 Days 126.60
  • 200 Days 137.70
135.75 PIVOT
First Support 120.10 First Resistance 144.00 Second Support 111.85 Second Resistance 159.65 Third Support 96.20 Third Resistance 167.90
RSI 51.32 ADX 28.58 MACD 1.42 Williams % R -79.54 Commodity Channel Index (CCI) 113.48
Date 2026-04-30 Week 3128.00 Same Day 4715.00 Month 3162.00
1 Year 0.64 3 Year 0.64
Over 1 Month
17.32% down
Over 1 Year
-22.84% down
Over 3 Months
-7.92% down
Over 3 Years
10.17% down
Over 6 Months
-17.71% down
Over 5 Years
-2.73% down

SOURCE NATURAL FOODS & HERBAL Corporate Actions

Top Gainers

Top Losers

SOURCE NATURAL FOODS & HERBAL Share Price

Source Natural Foods &Herbal Supplements Limited was initially incorporated as Inwinex Pharmaceuticals Limited in 1995. The Company name was then changed from Inwinex Pharmaceuticals Limited to Source Natural Foods &Herbal Supplements Limited in 2011-12. The Company engages in the pharmaceutical business in India and provide allopathic and ayurvedic formulations. Its principal products include Organic Ashwagandha, Organic Triphala, and Organic Satavari Tablets.

Company operates in the Ayurveda and herbal sphere which has been identified as one of the key sectors of growth and innovation for the Country. Company focuses on such products which will bring Ayurveda in to individual's daily diet. It provide various Ayurvedic products in the form of medicines and herbal supplements.

In 2000, the Company hived-off the bulk drug unit and diversified into software related activities by changing the Main Clause. In 2001, it signed an agreement with CDSL, NSDL and Venture Capital and Corporate Investment for dematerialization. The factory, located at Hyderabad in Andhra Pradesh, was completely shut down since April 12, 2006 due to inadequacy of working capital requirements.

In 2009, the Company entered the fast-growing Ayurveda products market with the goal of manufacturing the highest quality Ayurveda products and food supplements. In 2010, under the New Management, the facility earned the distinction of being the sole manufacturer for export quality products for distribution across the world.

The Company has planned to expand its product portfolio with new launches in Ayurvedic Medicines and Foods Supplements segments. The Company has been aggressively exploring and expanding its portfolios in green energy vertical. The Management is also focusing on diversification into wastewater and solid waste management during the year 2025.

Parent organization Indian Private
NSE symbol [-]
Founded 1995
stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Source Natural Foods & Herbal Supplements Ltd?

Answer Field

Source Natural Foods & Herbal Supplements Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 130.80 as on May 04 2026 03:28 PM.

What is the Market Cap of Source Natural Foods & Herbal Supplements Ltd Share?

Answer Field

The market cap of Source Natural Foods & Herbal Supplements Ltd for NSE ₹ 0.00 & for BSE ₹ 84.20 as on May 04 2026 03:28 PM.

What is the 52 Week High and Low of Source Natural Foods & Herbal Supplements Ltd?

Answer Field

The 52 Week High and Low of Source Natural Foods & Herbal Supplements Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 192.00 and ₹ 100.95.

What is 1 year return for Source Natural Foods & Herbal Supplements Ltd?

Answer Field

The 1 year returns on the stock has been -22.84%.

What is the P/E Ratio of Source Natural Foods & Herbal Supplements Ltd Share?

Answer Field

As on May 04 2026 03:28 PM the price-to-earnings (PE) ratio for Source Natural Foods & Herbal Supplements Ltd share is 29.47.

What is the PB ratio of Source Natural Foods & Herbal Supplements Ltd Share?

Answer Field

As on May 04 2026 03:28 PM, the price-to-book (PB) ratio for Source Natural Foods & Herbal Supplements Ltd share is 36.80.

How to Buy Source Natural Foods & Herbal Supplements Ltd Share?

Answer Field

You can trade in Source Natural Foods & Herbal Supplements Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Source Natural Foods & Herbal Supplements Ltd Share on Bajaj Broking App?

Answer Field

To buy Source Natural Foods & Herbal Supplements Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Source Natural Foods & Herbal Supplements Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|